跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Xenon
首页
药物
Xenon
Experimental
Small Molecule
Xenon
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
Xe
CAS 编号
7440-63-3
UNII ID
3H3U766W84
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Spiro-oxindole compounds and their use as therapeutic agents
CN 105175433 A
申请人: XENON PHARMACEUTICALS INC
优先权: 2008
CN
EP
US
11 件公开
US 2011112162 A9
申请人: XENON PHARMACEUTICALS INC
优先权: 2009
US
3 件公开
SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS
EP 3241834 A1
申请人: XENON PHARMACEUTICALS INC
优先权: 2005
EP
US
8 件公开
Synthetic methods for spiro-oxindole compounds
EP 2733145 A1
申请人: XENON PHARMACEUTICALS INC
优先权: 2009
EP
US
8 件公开
Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
CN 104650106 A
申请人: XENON PHARMACEUTICALS INC
优先权: 2009
CN
EP
US
7 件公开
PIPERAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS
EP 2316828 A1
申请人: XENON PHARMACEUTICALS INC
优先权: 2003
CN
EP
US
6 件公开
Pyridazine derivatives and their use as therapeutics agents
EP 2316826 A1
申请人: XENON PHARMACEUTICALS INC
优先权: 2003
CN
EP
US
6 件公开
HETEROARYL AMINE COMPOUNDS AND USES THEREOF
EP 4762053 A1
申请人: XENON PHARMACEUTICALS INC
优先权: 2023
CN
EP
WO
6 件公开
XENON GAS FOR USE IN THE TREATMENT OF GLIOMAS
EP 4119191 A1
申请人: UNIV HEIDELBERG
优先权: 2021
CN
EP
US
WO
5 件公开
METHODS OF TREATING DEPRESSIVE DISORDERS
EP 4054580 A1
申请人: XENON PHARMACEUTICALS INC
优先权: 2019
EP
US
WO
5 件公开
Use of xenon for treating neurointoxications
US 8143317 B2
申请人: PETZELT CHRISTIAN
优先权: 1999
CN
US
5 件公开
第 1 / 10 页
上一页
下一页
药物
反馈